Multiple Sclerosis (MS)

MS has increased significantly in recent decades in the industrialized countries of the temperate zones. The disease was first discovered in the 1870s when amalgam (52% of which is mercury) was introduced as a dental material. In 1989, Ahlrot-Westerlund demonstrated that the cerebrospinal fluid of MS patients showed a 7.5-fold increase in mercury exposure. Once the highly toxic amalgam was removed from MS patients, critical blood levels improved, pathological indicators in cerebrospinal fluid decreased, and psychological symptoms such as depression, aggressiveness, and even psychotic behavior subsided.

In animal experiments, it has been conclusively proven that numerous common environmental toxins cause MS-like symptoms.

The link between MS and chronic latent bacterial and viral infections is widely acknowledged by scientists.

There is concrete evidence that any antigen in the central nervous system can trigger autoimmune inflammation when administered experimentally (Gold and Brück, 2007). Patients with Alzheimer's disease developed MS as a result of vaccination with amyloid peptides, and there have been cases described in which patients developed MS following rabies vaccination.

In my own clinical experience, our numerous MS patients have in most cases been exposed to various neurotoxic agents (neurotoxins) and chronic infections such as Lyme disease and its co-infections as well as the Epstein-Barr virus.

In many cases, we are able to permanently relieve the typical MS symptoms.